- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Dongkook Pharmaceutical Co Ltd (086450)
Dongkook Pharmaceutical Co Ltd stock price live, this page displays KQ 086450 stock exchange data. View the 086450 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Dongkook Pharmaceutical Co Ltd real time stock price chart below.
What Is the Dongkook Pharmaceutical Co Ltd Stock Price Today?
The Dongkook Pharmaceutical Co Ltd stock price today is 17,720.
What Is the Stock Symbol for Dongkook Pharmaceutical Co Ltd?
The stock symbol for Dongkook Pharmaceutical Co Ltd is ""086450.""
What Stock Exchange Does Dongkook Pharmaceutical Co Ltd Trade On?
Dongkook Pharmaceutical Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is Dongkook Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Dongkook Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 086450 quote. (ISIN: KR7086450004)
What Is the Dongkook Pharmaceutical Co Ltd Stock Price Today?
The Dongkook Pharmaceutical Co Ltd stock price today is 17,720.
What Is the Stock Symbol for Dongkook Pharmaceutical Co Ltd?
The stock symbol for Dongkook Pharmaceutical Co Ltd is ""086450.""
What Stock Exchange Does Dongkook Pharmaceutical Co Ltd Trade On?
Dongkook Pharmaceutical Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is Dongkook Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Dongkook Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 086450 quote. (ISIN: KR7086450004)
KOSDAQ
Currency in KRW
17,720
+120(+0.68%)
Closed·
Fair Value
An estimate of a Dongkook Pharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17,600
18,030
52 wk Range
14,400
19,150
086450 Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
086450 is included in our AI-picked strategies. See how they work
Fair Value
An estimate of a Dongkook Pharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17,60018,030
52 wk Range
14,40019,150
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.13%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.13%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
086450 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Dongkook Pharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
23,000
Upside
+29.80%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell
Dongkook Pharmaceutical Co Ltd Company Profile
DongKook Pharmaceutical Co., Ltd. produces and sell pharmaceutical products in South Korea and internationally. The company offers non-prescription and prescription drugs, quasi drugs, medical devices, active pharmaceutical ingredients, cosmetics, and other processed products. Its pipeline includes DKF-MB601, used to treat Hepatitis B; DKF-MB501, to treat obesity; DKM-412 and DKM-420 to treat osteoarthritis; DKF-313, indicated for benign prostatic hyperplasia; DKF-447, to treat diabetes; DKB-123, used for wound healing, tissue repair; and DKM-428, used to protect skin. In addition, the company develops DKF-424, for the treatment of gastroesophageal reflux disease; DKF-427, used to treat antithrombotic; DKF-460, to treat Dyslipidemia; DKF-5122, for the treatment of Fungal Infection; DKF-MA201 and DKF-MB201, a acromegaly drugs; DKF-MB101, indicated for immunosuppression; and DKF-MA101 and DKF-MA102 to treat prostate cancer. The company was formerly known as UEC & Co., Ltd. and changed its name to DongKook Pharmaceutical Co., Ltd. in March 1982. The company was founded in 1968 and is headquartered in Seoul, South Korea.
Compare 086450 to Peers and Sector
Metrics to compare | 086450 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship086450PeersSector | |
|---|---|---|---|---|
P/E Ratio | 13.7x | 8.8x | −0.5x | |
PEG Ratio | 0.97 | 0.01 | 0.00 | |
Price/Book | 1.3x | 0.9x | 2.6x | |
Price / LTM Sales | 0.9x | 0.6x | 3.3x | |
Upside (Analyst Target) | 29.8% | 42.9% | 40.3% | |
Fair Value Upside | Unlock | 26.0% | 5.1% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 23,000
(+29.80% Upside)
Earnings
Latest Release
Aug 12, 2025
EPS / Forecast
-- / --
Revenue / Forecast
233.50B / 222.70B
People Also Watch
FAQ
What Stock Exchange Does Dongkook Pharmaceutical Trade On?
Dongkook Pharmaceutical is listed and trades on the KOSDAQ stock exchange.
What Is the Stock Symbol for Dongkook Pharmaceutical?
The stock symbol for Dongkook Pharmaceutical is "086450."
What Is the Dongkook Pharmaceutical Market Cap?
As of today, Dongkook Pharmaceutical market cap is 786.63B.
What Is Dongkook Pharmaceutical's Earnings Per Share (TTM)?
The Dongkook Pharmaceutical EPS (TTM) is 1,309.22.
When Is the Next Dongkook Pharmaceutical Earnings Date?
Dongkook Pharmaceutical will release its next earnings report on 12 Nov 2025.
From a Technical Analysis Perspective, Is 086450 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Dongkook Pharmaceutical Stock Split?
Dongkook Pharmaceutical has split 3 times.
How Many Employees Does Dongkook Pharmaceutical Have?
Dongkook Pharmaceutical has 1183 employees.
What is the current trading status of Dongkook Pharmaceutical (086450)?
As of 16 Aug 2025, Dongkook Pharmaceutical (086450) is trading at a price of 17,720.00, with a previous close of 17,600.00. The stock has fluctuated within a day range of 17,600.00 to 18,030.00, while its 52-week range spans from 14,400.00 to 19,150.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.